192 related articles for article (PubMed ID: 37216106)
1. MicroRNA-31 induced by
Tang B; Lu X; Tong Y; Feng Y; Mao Y; Dun G; Li J; Xu Q; Tang J; Zhang T; Deng L; He X; Lan Y; Luo H; Zeng L; Xiang Y; Li Q; Zeng D; Mao X
iScience; 2023 May; 26(5):106770. PubMed ID: 37216106
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum induces excess methyltransferase-like 3-mediated microRNA-4717-3p maturation to promote colorectal cancer cell proliferation.
Xu Q; Lu X; Li J; Feng Y; Tang J; Zhang T; Mao Y; Lan Y; Luo H; Zeng L; Xiang Y; Hu L; Zhang Y; Li Q; Deng L; He X; Tang B; Mao X; Zeng D
Cancer Sci; 2022 Nov; 113(11):3787-3800. PubMed ID: 35984699
[TBL] [Abstract][Full Text] [Related]
3. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
4. Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness.
Hong XL; Yu TC; Huang XW; Wang JL; Sun TT; Yan TT; Zhou CB; Chen HM; Su WY; Du W; Xiong H
Br J Cancer; 2023 Jan; 128(2):363-374. PubMed ID: 36396820
[TBL] [Abstract][Full Text] [Related]
5. Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum.
Feng YY; Zeng DZ; Tong YN; Lu XX; Dun GD; Tang B; Zhang ZJ; Ye XL; Li Q; Xie JP; Mao XH
PLoS One; 2019; 14(4):e0215088. PubMed ID: 30951563
[TBL] [Abstract][Full Text] [Related]
6.
Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
[TBL] [Abstract][Full Text] [Related]
7.
Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
[No Abstract] [Full Text] [Related]
8. A gene delivery system with autophagy blockade for enhanced anti-angiogenic therapy against Fusobacterium nucleatum-associated colorectal cancer.
Li N; Yu Y; Chen Q; Niu J; Gao C; Qu X; Zhang J; Gao H
Acta Biomater; 2024 Jun; ():. PubMed ID: 38838905
[TBL] [Abstract][Full Text] [Related]
9. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
10. The role of
Sun CH; Li BB; Wang B; Zhao J; Zhang XY; Li TT; Li WB; Tang D; Qiu MJ; Wang XC; Zhu CM; Qian ZR
Chronic Dis Transl Med; 2019 Sep; 5(3):178-187. PubMed ID: 31891129
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis.
Lu X; Xu Q; Tong Y; Zhang Z; Dun G; Feng Y; Tang J; Han D; Mao Y; Deng L; He X; Li Q; Xiang Y; Wang F; Zeng D; Tang B; Mao X
Cell Rep; 2022 Jul; 40(3):111127. PubMed ID: 35858553
[TBL] [Abstract][Full Text] [Related]
12. Both endogenous and exogenous miR-139-5p inhibit Fusobacterium nucleatum-related colorectal cancer development.
Zhao Y; Tao Q; Li S; Zheng P; Liu J; Liang X
Eur J Pharmacol; 2020 Dec; 888():173459. PubMed ID: 32768506
[TBL] [Abstract][Full Text] [Related]
13. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
[TBL] [Abstract][Full Text] [Related]
14. Exploring the interplay between
Bostanghadiri N; Razavi S; Shariati A; Talebi M; Mirkalantari S; Emami Razavi A; Darban-Sarokhalil D
Front Microbiol; 2023; 14():1302719. PubMed ID: 38075864
[TBL] [Abstract][Full Text] [Related]
15.
Zhang Y; Zhang L; Zheng S; Li M; Xu C; Jia D; Qi Y; Hou T; Wang L; Wang B; Li A; Chen S; Si J; Zhuo W
Gut Microbes; 2022; 14(1):2038852. PubMed ID: 35220887
[TBL] [Abstract][Full Text] [Related]
16. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.
Wang N; Fang JY
Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786
[TBL] [Abstract][Full Text] [Related]
17. Association between colorectal cancer and expression levels of miR-21, miR-17-5P, miR-155 genes and the presence of Fusobacterium nucleatum in biopsy samples obtained from Iranian patients.
Bostanshirin N; Hajikhani B; Vaezi AA; Kermanian F; Sameni F; Yaslianifard S; Goudarzi M; Dadashi M
Infect Agent Cancer; 2023 Mar; 18(1):14. PubMed ID: 36859379
[TBL] [Abstract][Full Text] [Related]
18. Targeting Programmed
Ganesan K; Guo S; Fayyaz S; Zhang G; Xu B
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635333
[TBL] [Abstract][Full Text] [Related]
19.
Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
[TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
